These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 32419012)

  • 1. Indurated Skin and Iron Overload-the Missing Link.
    Cao T; Chia HY; Lee JSS; Chong WS; Heng YK
    Ann Acad Med Singap; 2020 Apr; 49(4):268-270. PubMed ID: 32419012
    [No Abstract]   [Full Text] [Related]  

  • 2. Iron overload in porphyria cutanea tarda.
    Bygum A; Brandrup F
    Br J Dermatol; 2000 Nov; 143(5):1116. PubMed ID: 11069545
    [No Abstract]   [Full Text] [Related]  

  • 3. [Porphyria cutanea tarda, hemodialysis and HCV hepatopathy].
    Muray S; Casanova JM; Marco MP; Craver L; Martín M; Fernández E
    Nefrologia; 2002; 22(6):570-3. PubMed ID: 12516291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Porphyria cutanea tarda and melioidosis.
    Fung WK; Tam SC; Ho KM; Lam P; Lo KK
    Hong Kong Med J; 2001 Jun; 7(2):197-200. PubMed ID: 11514757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Iron overload and cutaneous disease: an emphasis on clinicopathological correlations.
    Englander L; Friedman A
    J Drugs Dermatol; 2010 Jun; 9(6):719-22. PubMed ID: 20645540
    [No Abstract]   [Full Text] [Related]  

  • 6. The additive effects of hepatitis C infection and end-stage renal disease in porphyria cutanea tarda.
    Chan OT; Tsai N; Wong RL; Izumi AK
    Cutis; 2006 Dec; 78(6):397-400. PubMed ID: 17243426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between porphyria cutanea tarda and beta-thalassemia major.
    Barbieri L; Macrì A; Lupia Palmieri G; Aurizi C; Biolcati G
    Cell Mol Biol (Noisy-le-grand); 2009 Jul; 55(2):36-9. PubMed ID: 19656449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Porphyria cutanea tarda, hepatitis C infection, and iron overload in a patient on hemodialysis.
    Albitar S; Bourgeon B; Chuet C
    Am J Med; 1999 Feb; 106(2):266-7. PubMed ID: 10230760
    [No Abstract]   [Full Text] [Related]  

  • 9. Lack of association between porphyria cutanea tarda and alpha 1-antitrypsin deficiency.
    Fargion S; Sergi C; Bissoli F; Fracanzani AL; Suigo E; Carazzone A; Roberto C; Cappellini MD; Fiorelli G
    Eur J Gastroenterol Hepatol; 1996 Apr; 8(4):387-91. PubMed ID: 8781910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyria cutanea tarda presenting as milia and blisters.
    Nguyen LH; Khamisa K
    CMAJ; 2018 May; 190(20):E623. PubMed ID: 29789288
    [No Abstract]   [Full Text] [Related]  

  • 11. Porphyria cutanea tarda.
    Fritsch C; Lang K; von Schmiedeberg S; Bolsen K; Merk H; Lehmann P; Ruzicka T
    Skin Pharmacol Appl Skin Physiol; 1998; 11(6):321-35. PubMed ID: 10343203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local necrotizing skin infections in an HIV patient with porphyria cutanea tarda.
    Au K; Boustred AM
    Plast Reconstr Surg; 2005 Mar; 115(3):975-6. PubMed ID: 15731731
    [No Abstract]   [Full Text] [Related]  

  • 13. S65c frequency in Italian patients with hemochromatosis, porphyria cutanea tarda and chronic viral hepatitis with iron overload.
    Trombini P; Mauri V; Salvioni A; Corengia C; Arosio C; Piperno A
    Haematologica; 2001 Mar; 86(3):316-7. PubMed ID: 11255280
    [No Abstract]   [Full Text] [Related]  

  • 14. A man with a blistering eruption and tuberculosis.
    Lee CH; Yuen MM; Chow WS; Tso AW; Yeung CK; Chan JC; Chau CH; Lam KS
    BMJ; 2012 Jan; 344():d8351. PubMed ID: 22228698
    [No Abstract]   [Full Text] [Related]  

  • 15. Porphyria Cutanea Tarda as the Initial Manifestation of Subclinical Hereditary Hemochromatosis.
    Trofymenko O; Sagerman P; Kurtzman DJB
    Clin Gastroenterol Hepatol; 2017 Sep; 15(9):A37-A38. PubMed ID: 28479501
    [No Abstract]   [Full Text] [Related]  

  • 16. Porphyria cutanea tarda in a hemodialysis patient.
    Huang YC; Wang CC; Sue YM
    QJM; 2013 Jun; 106(6):591-2. PubMed ID: 22753666
    [No Abstract]   [Full Text] [Related]  

  • 17. Genetic hemochromatosis in Italian patients with porphyria cutanea tarda: possible explanation for iron overload.
    Fargion S; Fracanzani AL; Romano R; Cappellini MD; Faré M; Mattioli M; Piperno A; Ronchi G; Fiorelli G
    J Hepatol; 1996 May; 24(5):564-9. PubMed ID: 8773911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the hemochromatosis gene in prophyria cutanea tarda. Prospective study of 56 cases].
    Skowron F; Bérard F; Grézard P; Wolf F; Morel Y; Perrot H
    Ann Dermatol Venereol; 2001 May; 128(5):600-4. PubMed ID: 11427792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Porphyria cutanea tarda].
    Fritsch C; von Schmiedeberg S; Lehmann P
    Hautarzt; 1998 Nov; 49(11):870-82; quiz 882. PubMed ID: 9879491
    [No Abstract]   [Full Text] [Related]  

  • 20. Porphyria cutanea tarda triggered by a combination of three predisposing factors.
    Barzilay D; Orion E; Brenner S
    Dermatology; 2001; 203(2):195-7. PubMed ID: 11586030
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.